PubMed

Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs.

Larrat S, Hilleret MN, Germi R, Lupo J, Nicod S, Zarski JP, Seigneurin JM, Morand P.

Comp Hepatol. 2008 Mar 12;7:3.PMID: 18336716 [PubMed]Related articlesFree article

Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues.

Wang F, Wang H, Shen H, Meng C, Weng X, Zhang W.

Clin Ther. 2009 Feb;31(2):360-6.PMID: 19302908 [PubMed - indexed for MEDLINE]Related articles

In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.

Qi X, Xiong S, Yang H, Miller M, Delaney WE 4th.

Antivir Ther. 2007;12(3):355-62.PMID: 17591025 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.

Santantonio T, Fasano M, Durantel S, Barraud L, Heichen M, Guastadisegni A, Pastore G, Zoulim F.

Antivir Ther. 2009;14(4):557-65.PMID: 19578241 [PubMed - indexed for MEDLINE]Related articles

Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.

Cha CK, Kwon HC, Cheong JY, Cho SW, Hong SP, Kim SO, Yoo WD.

J Med Virol. 2009 Mar;81(3):417-24.PMID: 19152409 [PubMed - indexed for MEDLINE]Related articles

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group.

Clin Ther. 2008 Feb;30(2):317-23.PMID: 18343270 [PubMed - indexed for MEDLINE]Related articles

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.

Zaaijer HL, Takkenberg RB, Weegink CJ, Rebers SP, Menting S, Reesink HW, Schinkel J, Molenkamp R.

J Med Virol. 2009 Mar;81(3):413-6.PMID: 19152408 [PubMed - indexed for MEDLINE]Related articles

Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.

Ohkawa K, Takehara T, Kato M, Kanada A, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.

J Med Virol. 2009 May;81(5):798-806.PMID: 19319954 [PubMed - indexed for MEDLINE]Related articles

[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection]

Moon JH, Cho M, Yoon KT, Bae JH, Heo J, Kim GH, Kang DH, Song GA.

Korean J Hepatol. 2008 Dec;14(4):503-12. Korean. PMID: 19119245 [PubMed - indexed for MEDLINE]Related articlesFree article

Monitoring of therapy in patients with chronic hepatitis B virus.

Arrese E, Basaras M, Blanco S, Ruiz P, Cisterna R.

Eur J Gastroenterol Hepatol. 2009 Jun 20. [Epub ahead of print]PMID: 19550344 [PubMed - as supplied by publisher]Related articles

Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.

Villet S, Pichoud C, Billioud G, Barraud L, Durantel S, Trépo C, Zoulim F.

J Hepatol. 2008 May;48(5):747-55. Epub 2008 Feb 25.PMID: 18331765 [PubMed - indexed for MEDLINE]Related articles

Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir.

Kurashige N, Ohkawa K, Hiramatsu N, Oze T, Yakushijin T, Mochizuki K, Hosui A, Miyagi T, Ishida H, Tatsumi T, Kanto T, Takehara T, Hayashi N.

Antivir Ther. 2009;14(6):873-7.PMID: 19812452 [PubMed - indexed for MEDLINE]Related articles

Clinical usefulness of sequential hepatitis B virus DNA measurement (the roadmap concept) during adefovir treatment in lamivudine-resistant patients.

Shin JW, Park NH, Jung SW, Park BR, Kim CJ, Jeong ID, Bang SJ, Kim do H.

Antivir Ther. 2009;14(2):181-6.PMID: 19430092 [PubMed - indexed for MEDLINE]Related articles

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant.

Ratziu V, Thibault V, Benhamou Y, Poynard T.

Comp Hepatol. 2006 Jan 11;5:1.PMID: 16405720 [PubMed]Related articlesFree article

Complex dynamics of hepatitis B virus resistance to adefovir.

Pallier C, Rodriguez C, Brillet R, Nordmann P, Hézode C, Pawlotsky JM.

Hepatology. 2009 Jan;49(1):50-9.PMID: 19065672 [PubMed - indexed for MEDLINE]Related articles

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.

Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, Naoumov NV.

J Med Virol. 2008 Jul;80(7):1160-70.PMID: 18461609 [PubMed - indexed for MEDLINE]Related articles

[Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients]

Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW.

Korean J Hepatol. 2008 Mar;14(1):58-66. Korean. PMID: 18367858 [PubMed - indexed for MEDLINE]Related articlesFree article

[A study on the treatment of chronic hepatitis B with YMDD mutation]

Qiu YW, Jiang XH, Huang LH, Hu TH, Ding H, Jiang YM, Dai YX, Zhou M.

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):171-4. Chinese. PMID: 19335977 [PubMed - in process]Related articles

Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response.

Rodriguez-Frias F, Jardi R, Schaper M, Buti M, Ferrer-Costa C, Tabernero D, Homs M, Esteban R.

Antivir Ther. 2008;13(8):991-9.PMID: 19195324 [PubMed - indexed for MEDLINE]Related articles

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Yatsuji H, Suzuki F, Sezaki H, Akuta N, Suzuki Y, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Watahiki S, Iwasaki S, Kobayashi M, Kumada H.

J Hepatol. 2008 Jun;48(6):923-31. Epub 2008 Apr 1.PMID: 18433925 [PubMed - indexed for MEDLINE]Related articles